Add BrightSurf on Google Email

Science News for February 26, 1998


Hybrid Antibody Created At National Jewish Medical And Research Center 'Turns Off' CD4 T Cells Responsible For Organ Transplant Rejection

A new hybrid antibody developed at National Jewish Medical and Research Center can selectively turn off only the CD4 T cells attacking transplanted organs, allowing the immune system to fight other illnesses without suppression. Clinical trials are estimated to take approximately two years.

SourceNational Jewish Health·JournalNature Biotechnology·DateFeb 26, 1998

Chemist Turns To Self-Assembly To Create New Drugs

Chemist Benjamin Miller has devised a way to create new drugs by using metal atoms to assemble countless combinations of molecules, then selecting the best candidates through a Darwinian process. This method shifts the burden of tedious drug development work off technicians' shoulders, offering a faster and more efficient approach.

SourceUniversity of Rochester·JournalTetrahedron Letters·DateFeb 26, 1998